Back to search

Article

Effect of Paxlovid Treatment During Acute Covid-19 on Long Covid Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER Consortia

2024-01-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Preventing and treating post-acute sequelae of SARS-CoV-2 infection (PASC), commonly known as Long COVID, has become a public health priority. Researchers have begun to explore whether Paxlovid treatment in the acute phase of COVID-19 could help prevent the onset of PASC. <h4>Methods and Findings</h4> We used electronic health records from the National Clinical Cohort Colla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0f3985fc-6db0-59b5-8c88-6090ffe68aef
DOI
10.1101/2024.01.20.24301525
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of Paxlovid Treatment During Acute Covid-19 on Long Covid Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER ConsortiaDOI 10.1101/2024.01.20.24301525
Select a neighboring publication to make it the new centre.